We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$337M
AUM Growth
-$2.19M
Cap. Flow
-$24.3M
Cap. Flow %
-7.21%
Top 10 Hldgs %
33.68%
Holding
47
New
1
Increased
9
Reduced
35
Closed
1

Top Buys

Rank Stock Value
1
MAR icon
Marriott International
MAR
+$906K
2
KO icon
Coca-Cola
KO
+$192K
3
IFF icon
International Flavors & Fragrances
IFF
+$158K
4
DE icon
Deere & Co
DE
+$101K
5
BMY icon
Bristol-Myers Squibb
BMY
+$89K

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$1.74M
2
MSFT icon
Microsoft
MSFT
+$1.35M
3
UNH icon
UnitedHealth
UNH
+$1.3M
4
V icon
Visa
V
+$1.22M
5
PFE icon
Pfizer
PFE
+$1.08M

Sector Composition

Rank Sector Weight
1 Healthcare 31.09%
2 Technology 13.51%
3 Financials 10.93%
4 Consumer Discretionary 9.41%
5 Utilities 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
1
Danaher
DHR
$145B
$12.3M 3.64%
127,165
-9,250
-7% -$842K
UNH icon
2
UnitedHealth
UNH
$364B
$12.1M 3.61%
45,645
-5,000
-10% -$1.3M
V icon
3
Visa
V
$671B
$11.6M 3.44%
77,180
-8,550
-10% -$1.22M
MSFT icon
4
Microsoft
MSFT
$3.66T
$11.6M 3.44%
101,277
-12,425
-11% -$1.35M
MRK icon
5
Merck
MRK
$328B
$11.2M 3.32%
165,281
-16,244
-9% -$1.03M
ADBE icon
6
Adobe
ADBE
$103B
$11.1M 3.3%
41,220
-3,850
-9% -$993K
PFE icon
7
Pfizer
PFE
$150B
$11.1M 3.28%
264,301
-27,984
-10% -$1.08M
ORCL icon
8
Oracle
ORCL
$442B
$10.8M 3.22%
210,300
-10,300
-5% -$500K
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.2T
$10.8M 3.22%
179,500
-16,600
-8% -$1M
BA icon
10
Boeing
BA
$183B
$10.8M 3.2%
28,980
-1,705
-6% -$599K
AEP icon
11
American Electric Power
AEP
$67.9B
$10.8M 3.19%
151,740
+175
+0.1% +$12.5K
T icon
12
AT&T
T
$166B
$10.6M 3.14%
416,605
-32,702
-7% -$801K
DD icon
13
DuPont de Nemours
DD
$19.5B
$10.5M 3.12%
64,597
-3,218
-5% -$554K
CCL icon
14
Carnival Corporation Ltd
CCL
$37.9B
$10.5M 3.11%
164,275
-10,000
-6% -$607K
ICE icon
15
Intercontinental Exchange
ICE
$85B
$10.5M 3.11%
139,800
-11,700
-8% -$880K
DHI icon
16
D.R. Horton
DHI
$40.8B
$10.2M 3.03%
242,050
-17,225
-7% -$745K
ABT icon
17
Abbott
ABT
$192B
$10.2M 3.03%
138,885
-12,500
-8% -$821K
ABBV icon
18
AbbVie
ABBV
$440B
$10.2M 3.02%
107,585
-3,100
-3% -$294K
APTV icon
19
Aptiv
APTV
$10.1B
$10.1M 2.99%
119,875
-6,210
-5% -$567K
FDX icon
20
FedEx
FDX
$77.3B
$9.85M 2.92%
40,885
-2,450
-6% -$593K
D icon
21
Dominion Energy
D
$59.8B
$9.71M 2.88%
138,115
-10,300
-7% -$729K
DUK icon
22
Duke Energy
DUK
$96.3B
$9.52M 2.83%
118,925
-12,375
-9% -$1M
ALXN
23
DELISTED
Alexion Pharmaceuticals
ALXN
$9.4M 2.79%
67,635
-13,900
-17% -$1.74M
TMO icon
24
Thermo Fisher Scientific
TMO
$223B
$9.02M 2.68%
36,940
-3,870
-9% -$890K
AVGO icon
25
Broadcom
AVGO
$1.98T
$8.98M 2.67%
363,900
-21,500
-6% -$482K
1
2

Similar funds

LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
BC
Blackstart Capital New York $151M AUM 14.01% 1-Year Est. Return
JT
Jump Trading Chicago, Illinois $150M AUM 17.61% 1-Year Est. Return
SCM
Stellar Capital Management Phoenix, Arizona $147M AUM 5.91% 1-Year Est. Return
HF
Hellman & Friedman San Francisco, California $169M AUM
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return

Stralem & Co's Q3 2018 Portfolio in Review

As of Q3 2018, Stralem & Co held 47 positions worth $337M, down 0.65% from $339M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Stralem & Co withdrew a net $24.3M in Q3 2018, closing 1 position and reducing 35 holdings. Its most notable exit was Eli Lilly, an estimated $956K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 30% a quarter earlier, followed by Technology and Financials.

Against the trend, Stralem & Co opened a new position in Marriott International worth $937K.

  • Stralem & Co's largest Q3 2018 buy was Marriott International: 7,100 shares worth $937K.
  • Stralem & Co added most to Coca-Cola in Q3 2018, an estimated $192K increase.
  • Stralem & Co's biggest Q3 2018 reduction was Alexion Pharmaceuticals, cutting an estimated $1.74M.
  • Stralem & Co fully exited Eli Lilly in Q3 2018, selling an estimated $956K.
  • Stralem & Co's ten largest holdings make up 34% of its $337M portfolio in Q3 2018.
  • Stralem & Co opened 1 new position and closed 1 in Q3 2018.
  • Stralem & Co's portfolio value fell 0.65% quarter-over-quarter to $337M.

Based on Stralem & Co's 13F filing for Q3 2018, filed 17 Oct 2018.